Invitrogen this week announced that James Glynn, a member of its board of directors and chief executive officer emeritus, will retire as of April 21. Upon his retirement, Invitrogen will reduce its board size from 10 members to nine.
Already have a GenomeWeb or 360Dx account?Login Now.
A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.
Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.
In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.
A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.